The US Federal Reserve left the rate unchanged, but revised its inflation and growth forecasts, reinforcing fears of possible "moderate stagflation". In parallel, tense negotiations continue between Microsoft and OpenAI: the former threatens to withdraw from the deal if it does not get more favorable terms of access to AI technologies, while the developer ChatGPT seeks to complete the transformation into a commercial structure and attract funding. Against a backdrop of geopolitical instability, Donald Trump is considering a military strike on Iran, heightening tensions over the conflict with Israel. About these and other topics - in the review of key events for the morning of June 19.

Circle Internet Group

Several banks, including JPMorgan, have announced plans to create their own stablecoins this year

The passage of the Stablecoin Bill has led to a USDC issuer rally. Who else won?

This decision was taken by OpenAI against the backdrop of strained relations between the partners

OpenAI has started selling its chatbot at a discount. This is a blow to its investor Microsoft

Major US stock indices lost gains as Powell speaks


"We haven't encountered anything like this." Fed head says he expects prices to rise in summer due to duties

Broadcom ranked seventh among S&P 500 players by market capitalization, surpassing Berkshire Hathaway investment guru Warren Buffett's Berkshire Hathaway


"A worthy replacement for Tesla": analysts have named a new candidate for the Magnificent Seven

Despite Trump's calls for a sharp rate cut, the regulator continues to take a wait-and-see attitude


Fed didn't change rate for the fourth time in a row, but predicts 2 rate cuts in 2025


The main UK index, the FTSE 100, is heavily weighted towards energy companies and traditionally defensive stocks

Citi named the UK market as the best defense against geopolitics. Where can you invest?

The analyst sees a 20% growth potential for the company's securities

Guggenheim raised its target price on Oracle stock to the highest level on Wall Street

Data

Quotes of John Wiley &amp; Sons, commonly known as Wiley, a small-cap publishing company that focuses on academic publishing and instructional materials, <a href="https://www.marketwatch.com/investing/stock/wly">soared</a>&nbsp;10% yesterday, June 17. The driver was the company's&nbsp;<a href="https://s27.q4cdn.com/812717746/files/doc_financials/2025/q4/Q425-Earnings-Presentation.pdf">financial results</a>&nbsp;for the fiscal-2025 fourth quarter and full year, which beat&nbsp;Wall Street forecasts. The company fingered its leveraging of AI as one of the reasons for the performance.

Earnings of small publisher Wiley beat expectations amid AI push

Quotes of Sarepta Therapeutics, a small-cap developer of precision genetic medicines to treat rare neuromuscular and central nervous system diseases, plummeted 42% yesterday, June 16, to hit a nine-year low. The company reported the death of the second teenager in three months who was taking its drug to treat muscular dystrophy. In addition, Sarepta has withdrawn its revenue guidance for 2025 as it may be forced to pull the drug from the market, analysts warn.

Sarepta tanks after death of second teen taking its gene therapy; outlook 'cloudy'

AIRO Group Holdings 

Airo Group Holdings, a small-cap drone maker, has&nbsp;<a href="https://www.marketwatch.com/story/heres-why-drone-maker-airos-stock-is-still-hot-despite-weak-demand-for-the-ipo-e6a268f0?mod=home_lead">soared</a> to nearly three times its IPO price in the first two days of trading, though shares were offered at well below the expected price. Airo is set to benefit as demand for military drones grows worldwide, analysts say.&nbsp;&nbsp;

After weak IPO, drone maker Airo soars amid Israel-Iran conflict, rising drone demand

Since the beginning of the year, Regencell Bioscience Holdings, a Hong Kong-based and Nasdaq-listed company that develops traditional Chinese medicine, <a href="https://finance.yahoo.com/quote/RGC/">has soared</a>&nbsp;more than 46,000%, <a href="https://www.bloomberg.com/news/articles/2025-06-16/herbal-medicine-stock-with-no-sales-sees-wild-rally-top-64-000?sref=Y0jVLcFo&amp;embedded-checkout=true">Bloomberg</a>&nbsp;wrote yesterday.&nbsp;Just a year ago, the company was worth about $53 million, while now its market capitalization is approaching $30 billion, even though it has never turned a profit and has zero revenue.&nbsp;

Herbal medicine maker Regencell Bioscience skyrockets 46,000% this year on no news

In 2025, digital forensics and cybersecurity technologies are increasingly in the spotlight due to rising numbers of cyberattacks and growing regulatory requirements. The U.S. SEC&nbsp;<a href="https://auditboard.com/blog/sec-cybersecurity-rules">requires</a> public companies to report major cyber incidents within four business days, and a&nbsp;<a href="https://www.cyberseek.org/docs/06-02-2025_CyberSeek_June_2025.pdf">shortage</a> of specialists is spurring demand for automated solutions. As a result, the global digital forensics market is growing rapidly, with&nbsp;<a href="https://www.marketsandmarkets.com/PressReleases/digital-forensics.asp">expected</a>&nbsp;growth from $13 billion in 2025 to over $22 billion by 2030.&nbsp;

Top stories for the morning: Fed keeps rate on hold, Microsoft vs. OpenAI, Trump decides on Iran

The passage of the Stablecoin Bill has led to a USDC issuer rally. Who else won?

OpenAI has started selling its chatbot at a discount. This is a blow to its investor Microsoft

«We haven't encountered anything like this.» Fed head says he expects prices to rise in summer due to duties

«A worthy replacement for Tesla»: analysts have named a new candidate for the Magnificent Seven

Fed didn't change rate for the fourth time in a row, but predicts 2 rate cuts in 2025

Citi named the UK market as the best defense against geopolitics. Where can you invest?

Guggenheim raised its target price on Oracle stock to the highest level on Wall Street

Stock Screener

Buy

Sell

Small Caps

Earnings of small publisher Wiley beat expectations amid AI push

Sarepta tanks after death of second teen taking its gene therapy; outlook 'cloudy'

After weak IPO, drone maker Airo soars amid Israel-Iran conflict, rising drone demand

Herbal medicine maker Regencell Bioscience skyrockets 46,000% this year on no news

Six small caps punching above their weight in the cybersecurity market